Literature DB >> 12509629

Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.

K-H Sun1, S-J Tang, Y-S Wang, W-J Lin, R-I You.   

Abstract

OBJECTIVE: This study was designed to clarify the internalization of anti-DNA antibodies (anti-DNA) into living cells in the pathogenesis of systemic lupus erythematosus (SLE) using anti-DNA monoclonal antibodies (mAbs).
METHODS: Anti-DNA mAbs 9D7, 9D7D2, 9A4, 5E3F5, 12B3H2 and 6E11E3 were prepared by a standard hybridoma procedure to determine the interaction of anti-DNA with proteins in different types of cells.
RESULTS: The anti-DNA mAbs reacted with two protein antigens (35 and 50 kDa) in the cells. The 35-kDa antigen was shown to have 100% homology with hnRNP A2. The arginine-glycine-rich domain in hnRNP A2 was found to be the reaction site, and the methylation of hnRNP A2 by PRMT1 (protein arginine methyltransferase 1) was increased by anti-DNA. Moreover, anti-DNA was demonstrated to bind and internalize into the cytoplasm and nucleus.
CONCLUSION: Nuclear localizing anti-DNA may cross-react with hnRNP A2 to modulate the inflammatory responses and polarize immune reactions associated with SLE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509629     DOI: 10.1093/rheumatology/keg060

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Direct mass-spectrometric identification of Arg296 and Arg299 as the methylation sites of hnRNP K protein for methyltransferase PRMT1.

Authors:  Yi-Ying Chiou; Wey-Jinq Lin; Shu-Ling Fu; Chao-Hsiung Lin
Journal:  Protein J       Date:  2007-02       Impact factor: 2.371

Review 2.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

3.  Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes.

Authors:  Annalisa Rossi; Albertomaria Moro; Toma Tebaldi; Nicola Cornella; Lisa Gasperini; Lorenzo Lunelli; Alessandro Quattrone; Gabriella Viero; Paolo Macchi
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

4.  Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody.

Authors:  Hyunjoon Park; Minjae Kim; Hye-Jin Kim; Yeonjin Lee; Youngsil Seo; Chuong D Pham; Joungmin Lee; Sung June Byun; Myung-Hee Kwon
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

5.  Cytosolic Internalization of Anti-DNA Antibodies by Human Monocytes Induces Production of Pro-inflammatory Cytokines Independently of the Tripartite Motif-Containing 21 (TRIM21)-Mediated Pathway.

Authors:  Hyunjoon Park; Minjae Kim; Youngsil Seo; Yeonkyoung Ham; Mi-Young Cho; Myung-Hee Kwon
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

Review 6.  Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases.

Authors:  Anna Łuczak; Marta Madej; Agata Kasprzyk; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-04-13       Impact factor: 6.543

7.  SPRi-based strategy to identify specific biomarkers in systemic lupus erythematosus, rheumatoid arthritis and autoimmune hepatitis.

Authors:  Elvire Beleoken; Hervé Leh; Armelle Arnoux; Béatrice Ducot; Claude Nogues; Eleonora De Martin; Catherine Johanet; Didier Samuel; Mohammad Zahid Mustafa; Jean-Charles Duclos-Vallée; Malcolm Buckle; Eric Ballot
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

8.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.